← FDA DRUG APPROVALS

FDA ANDA · ANDA077548

ONDANSETRON

Sponsor: HOSPIRA

APPLICATION
ANDA077548
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-26
LATEST ACTION
2025-11-18
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEPrescription
ONDANSETRON HYDROCHLORIDE EQ 2MG BASE/ML · INJECTABLE · INJECTION

Approval history

2025-11-18Labeling · Supplement 22 · standardAP
2022-03-15Labeling · Supplement 15 · standardAP
2021-09-01Labeling · Supplement 14 · standardAP
2021-09-01Labeling · Supplement 11 · standardAP
2015-01-20Labeling · Supplement 9 · standardAP
2013-12-24Labeling · Supplement 7 · standardAP
2013-12-24Labeling · Supplement 8 · standardAP
2006-12-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →